To gain insights into the factors that may be driving CD4+ and CD8+ T-cell activation and proliferation and define the nature of any persistent inflammation in these patients, we investigated the presence of soluble circulating pro-inflammatory cytokines/chemokines in the plasma of COVID-19 patients 3 months after admission. The gene discussed is CD4; the disease is COVID-19.